Rankings
▼
Calendar
BCYC Q2 2018 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$3M
-196.0% margin
Operating Income
-$5M
-298.5% margin
Net Income
-$5M
-299.8% margin
EPS (Diluted)
$-0.37
QoQ Revenue Growth
-40.8%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$335,000
← FY 2018
All Quarters
Q3 2018 →